Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Polycythemia Vera × Interferon-alpha × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

ruxolitinib 4 Specimen Handling 3 Biopsy 3 Hydroxyurea 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 talazoparib 1 piperine 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1 fludarabine phosphate 1 fludarabine 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 X-Rays 1 Whole-Body Irradiation 1 Watchful Waiting 1 Tacrolimus 1 Stem Cell Transplantation 1 Positron-Emission Tomography 1 N(4)-oleylcytosine arabinoside 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Interferons 1 Interferon-alpha 1 Injections 1 Hematopoietic Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116502 2024-11-18

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡